3,4-Di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands,申请号NZ20030538521-传众专利搜索

发明名称	3,4-Di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
摘要	Disclosed are cyclobutenedione compounds of formula (IB), which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
申请公布号	NZ538521(A)	申请公布日期	2008.02.29
申请号	NZ20030538521	申请日期	2003.07.30
申请人	SCHERING CORPORATION;PHARMACOPEIA, INC.	发明人	TAVERAS, ARTHUR G;AKI, CYNTHIA J;CHAO, JIANPING;DWYER, MICHAEL;CHAO, JIANHUA;YU, YOUNONG;MERRITT, J ROBERT;BIJU, PURAKKATTLE;JAKWAY, JAMES;LAI, GAIFA;WU, MINGLANG;HECKER, EVAN A;LUNDELL, DANIEL;FINE, JAY S
分类号	A61K31/166;A61K31/18;A61K31/341;A61K31/343;A61K31/357;A61K31/381;A61K31/40;A61K31/4025;A61K31/422;A61K31/472;A61K31/506;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P7/02;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P11/14;A61P13/12;A61P17/00;A61P17/02;A61P17/06;A61P17/10;A61P19/02;A61P19/06;A61P19/10;A61P25/00;A61P25/28;A61P27/02;A61P27/16;A61P29/00;A61P31/00;A61P31/04;A61P31/12;A61P31/14;A61P31/18;A61P33/06;A61P35/00;A61P37/06;C07C225/20;C07C237/30;C07C237/36;C07C237/44;C07C255/59;C07C311/39;C07D207/32;C07D207/335;C07D213/74;C07D217/24;C07D295/26;C07D307/38;C07D307/52;C07D307/56;C07D307/68;C07D307/79;C07D307/81;C07D307/82;C07D307/83;C07D317/46;C07D319/18;C07D333/20;C07D333/36;C07D333/40;C07D405/12;C07D409/12;C07D409/14;C07D413/12;C07D413/14;(IPC1-7):C07C237/36;C07D207/323;A61K31/36;A61K31/402;A61K31/42;A61K31/496;A61K31/537	主分类号	A61K31/166
代理机构		代理人
主权项
地址